Since GENS reported 4Q17 EBITDA fell 20% q-o-q to $255.1 million, its share price has tumbled 14%.
SINGPAPORE (Apr 10): Maybank Kim Eng is reiterating its “buy” call on Genting Singapore (GENS) with $1.46 target.
“In our view, all signals point to the VIP and mass markets improving going forward and GENS’s current share price is unjustified as it implies ‘crisis’ valuations,” says analyst Yin Shao Yang in a Monday report.
